Cannashield Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Occupational Asthma Rising Among Cannabis Workers, Multi-State Study Finds
A new multi-state study found rising cases of occupational asthma — and some fatalities — among cannabis cultivation, trimming, and packaging workers. The research highlights urgent gaps in workplace safety as the cannabis industry scales and underscores the need for stronger compliance and protection.
Tribal Cannabis Leaders Urge Rapid Adaptation Ahead of Federal Hemp-THC Rules
At the ICIA Summit, tribal leaders warned that federal hemp-THC regulations could heavily disrupt tribal cannabis markets if operators don’t adapt quickly. The message was clear: sovereignty is a strength, but proactive compliance and strategic planning are essential for long-term success.
Congress Narrows Hemp Definition and Bans Synthetic Cannabinoids, Reshaping the THC Market
Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.
Federal Funding Bill Could Ban Most Ingestible Hemp-Derived THC Products
A proposed federal spending bill includes language that could ban most ingestible hemp-derived THC products, threatening an estimated $28 billion industry. The measure would eliminate Delta-8, THCA, and other intoxicating hemp items — reshaping the national marketplace overnight.
How a Woman-Led Biotech Firm Is Advancing Cannabis Medicine
A woman-led biotech company is developing prescription-grade cannabinoid treatments for women’s health conditions like endometriosis. Their work aims to bring cannabis into mainstream medical and pharmaceutical channels — marking a breakthrough moment for both science and the cannabis industry.
Federal Spending Bill Includes Hemp Product Ban
A federal spending bill to reopen the government includes provisions to ban many hemp-derived THC products, such as Delta-8 and hemp-based gummies and beverages. The move could devastate parts of the hemp industry and signals increasing federal intervention in cannabis regulation.
U.S. Hemp Roundtable Warns Senate Proposal Could “Wipe Out” 95% of the Industry
The U.S. Hemp Roundtable warns that new Senate language could “wipe out” 95% of the hemp industry, eliminating thousands of jobs and billions in revenue. The group is urging Congress to remove the proposal from the federal spending bill and pursue balanced hemp regulation instead.
New Study Finds Cannabis Access Linked to Lower Heavy Alcohol Use
A new Oregon study finds that adults living near licensed cannabis stores report less heavy drinking and more marijuana use, especially among Gen Z and Baby Boomers. The findings suggest cannabis access may be replacing alcohol as a preferred wellness or social alternative.
Mainstream Brands Join the Cannabis Space with Hemp-Derived THC Products (Copy)
Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.
Mainstream Brands Join the Cannabis Space with Hemp-Derived THC Products
A major edible-fruit brand is launching hemp-derived THC gummies and beverages aimed at wellness consumers seeking alcohol-free relaxation. The move highlights how mainstream companies are entering the cannabis ecosystem amid evolving regulations and rising consumer demand.
Curaleaf Reports $320M in Revenue, $54.5M Net Loss in Q3
Curaleaf reported Q3 revenue of $320 million and a net loss of $54.5 million, reflecting both strength and ongoing financial strain across large multi-state cannabis operators. The results highlight the industry’s shift toward sustainable growth and disciplined risk management.
Green Thumb Industries Posts Strong Q3 Results Amid Industry Headwinds
Green Thumb Industries (GTI) reported Q3 revenue of $291.4 million, net income of $23.3 million, and $74.1 million in cash flow from operations. The strong performance highlights the company’s disciplined growth strategy and financial stability amid industry headwinds.
Minnesota’s Attorney General Calls for Federal Clarity on Hemp
Minnesota Attorney General Keith Ellison is urging Congress to close the Farm Bill “loophole” that created confusion around hemp-derived THC products. He says updated federal rules are essential to help legitimate hemp businesses thrive while ensuring fair competition and consumer safety.
Republican Support for Federal Cannabis Legalization Drops to 40%
Republican support for federal cannabis legalization has dropped from 55% to 40%, according to a new Gallup poll. The decline highlights growing political polarization around cannabis — and potential challenges for federal reform heading into 2026.
Michigan’s Cannabis Industry Challenges New Excise Tax in Court
Michigan’s cannabis industry has filed a lawsuit seeking to delay a new excise tax, arguing it will harm legal operators and drive consumers to the illicit market. The outcome could set a national precedent for how states balance taxation and market stability.
Minnesota and the Fond du Lac Band Sign Historic Cannabis Compact
Minnesota Governor Tim Walz and the Fond du Lac Band of Lake Superior Chippewa signed a historic cannabis compact establishing shared regulatory authority. The agreement strengthens state-tribal collaboration and sets a new national example for responsible, inclusive cannabis market development.
Hemp and the Hill: How a Federal Funding Bill Sparked a Cannabis Policy Standoff
Lawmakers are clashing over hemp-derived THC restrictions as part of a federal funding bill, sparking a political standoff that could shape the future of hemp regulation. The outcome could redefine how hemp and cannabis are governed nationwide.
Michigan’s Cannabis Market Faces a Potential Shake-Up
Michigan’s $3 billion cannabis market is preparing for regulatory and structural shifts that could reshape competition, pricing, and licensing. As one of the country’s most important cannabis economies, the state’s next moves will define the future of its industry.
Cannabis Industry Settlement Highlights Risks of Overexpansion
A major settlement between multi-state cannabis operators resolves years of litigation tied to a failed $860 million acquisition. The case highlights how the industry’s early expansion mistakes still shape today’s market — and why risk management is essential for modern cannabis operators.
Maine Issues Statewide Recall of Cannabis Vape Cartridges
Maine regulators issued a statewide recall of cannabis vape cartridges following a reported consumer health incident. The case highlights the need for stronger compliance systems, product traceability, and proactive risk management across the cannabis industry.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to get you cover?
Call us on (323)905-3396
or growth@cannashield.io

France may finally publish the regulatory texts needed to move medical cannabis beyond its long running pilot program in July 2026. The bigger lesson is that even with new study data showing opioid and analgesic reductions, the real market opportunity still depends on reimbursement, product registration, and patient access rules.